Cellectis (CLLS) Interest Coverage Ratio Growth (1y) (2016 - 2026)
Cellectis (CLLS) Interest Coverage Ratio Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -60.44% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 787.12% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -100.36% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 53.59% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -32.04% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 73.00% |
| 10 | Cellectis | 281.48 Mn | 95.81 Mn | - | 309.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 309.23% |
| Dec 31, 2025 | 18.22% |
| Sep 30, 2025 | -205.43% |
| Jun 30, 2025 | -52.93% |
| Mar 31, 2025 | -79.23% |
| Dec 31, 2024 | 49.61% |
| Sep 30, 2024 | 178.05% |
| Jun 30, 2024 | 193.94% |
| Mar 31, 2024 | 47.21% |
| Dec 31, 2023 | -80.04% |
| Sep 30, 2023 | -103.56% |
| Jun 30, 2023 | -106.81% |
| Mar 31, 2023 | -78.97% |
| Dec 31, 2022 | 93.99% |
| Sep 30, 2022 | 229.77% |
| Jun 30, 2022 | -43.46% |
| Mar 31, 2022 | -88.11% |
| Dec 31, 2021 | -36.05% |
| Sep 30, 2021 | 40.86% |
| Jun 30, 2021 | 277.82% |